These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1323485)

  • 1. Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease.
    Ledesma MD; Correas I; Avila J; Díaz-Nido J
    FEBS Lett; 1992 Aug; 308(2):218-24. PubMed ID: 1323485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5.
    Baumann K; Mandelkow EM; Biernat J; Piwnica-Worms H; Mandelkow E
    FEBS Lett; 1993 Dec; 336(3):417-24. PubMed ID: 8282104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.
    Paudel HK; Lew J; Ali Z; Wang JH
    J Biol Chem; 1993 Nov; 268(31):23512-8. PubMed ID: 8226879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.
    Hanger DP; Hughes K; Woodgett JR; Brion JP; Anderton BH
    Neurosci Lett; 1992 Nov; 147(1):58-62. PubMed ID: 1336152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for cdk5 as a major activity phosphorylating tau protein in porcine brain extract.
    Hosoi T; Uchiyama M; Okumura E; Saito T; Ishiguro K; Uchida T; Okuyama A; Kishimoto T; Hisanaga S
    J Biochem; 1995 Apr; 117(4):741-9. PubMed ID: 7592534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state.
    Drewes G; Lichtenberg-Kraag B; Döring F; Mandelkow EM; Biernat J; Goris J; Dorée M; Mandelkow E
    EMBO J; 1992 Jun; 11(6):2131-8. PubMed ID: 1376245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase FA/glycogen synthase kinase-3 alpha after heparin potentiation phosphorylates tau on sites abnormally phosphorylated in Alzheimer's disease brain.
    Yang SD; Yu JS; Shiah SG; Huang JJ
    J Neurochem; 1994 Oct; 63(4):1416-25. PubMed ID: 7931292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease.
    Ono T; Yamamoto H; Tashima K; Nakashima H; Okumura E; Yamada K; Hisanaga S; Kishimoto T; Miyakawa T; Miyamoto E
    Neurochem Int; 1995 Mar; 26(3):205-15. PubMed ID: 7787767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p44mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons.
    Lu Q; Soria JP; Wood JG
    J Neurosci Res; 1993 Jul; 35(4):439-44. PubMed ID: 7689658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau.
    Lichtenberg-Kraag B; Mandelkow EM; Biernat J; Steiner B; Schröter C; Gustke N; Meyer HE; Mandelkow E
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5384-8. PubMed ID: 1376918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
    Zheng-Fischhöfer Q; Biernat J; Mandelkow EM; Illenberger S; Godemann R; Mandelkow E
    Eur J Biochem; 1998 Mar; 252(3):542-52. PubMed ID: 9546672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein.
    Hasegawa M; Jakes R; Crowther RA; Lee VM; Ihara Y; Goedert M
    FEBS Lett; 1996 Apr; 384(1):25-30. PubMed ID: 8797796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of tau by glycogen synthase kinase-3 beta in vitro produces species with similar electrophoretic and immunogenic properties to PHF-tau from Alzheimer's disease brain.
    Mulot SF; Hughes K; Woodgett JR; Anderton BH; Hanger DP
    Biochem Soc Trans; 1995 Feb; 23(1):45S. PubMed ID: 7758758
    [No Abstract]   [Full Text] [Related]  

  • 14. The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease.
    Illenberger S; Zheng-Fischhöfer Q; Preuss U; Stamer K; Baumann K; Trinczek B; Biernat J; Godemann R; Mandelkow EM; Mandelkow E
    Mol Biol Cell; 1998 Jun; 9(6):1495-512. PubMed ID: 9614189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microtubule-associated protein tau is phosphorylated by protein kinase C on its tubulin binding domain.
    Correas I; Díaz-Nido J; Avila J
    J Biol Chem; 1992 Aug; 267(22):15721-8. PubMed ID: 1639808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of synthetic phospho- and unphospho- peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's disease.
    Liu WK; Moore WT; Williams RT; Hall FL; Yen SH
    J Neurosci Res; 1993 Feb; 34(3):371-6. PubMed ID: 8455212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding.
    Biernat J; Gustke N; Drewes G; Mandelkow EM; Mandelkow E
    Neuron; 1993 Jul; 11(1):153-63. PubMed ID: 8393323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau protein kinase II has a similar characteristic to cdc2 kinase for phosphorylating neurofilament proteins.
    Hisanaga S; Ishiguro K; Uchida T; Okumura E; Okano T; Kishimoto T
    J Biol Chem; 1993 Jul; 268(20):15056-60. PubMed ID: 8325881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the phosphorylation of microtubule-associated protein tau by non-proline dependent protein kinases.
    Singh TJ; Grundke-Iqbal I; McDonald B; Iqbal K
    Mol Cell Biochem; 1994 Feb; 131(2):181-9. PubMed ID: 8035784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease.
    Brion JP; Smith C; Couck AM; Gallo JM; Anderton BH
    J Neurochem; 1993 Dec; 61(6):2071-80. PubMed ID: 8245963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.